Inactive Instrument

News Mind Medicine (MindMed) Inc. Other OTC

Equities

MMEDF

CA60255C1095

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Leerink Partners Starts Mind Medicine (MindMed) With Outperform Rating, $20 Price Target	Apr. 15	MT
MindMed to Present at Upcoming April Medical Conferences	Apr. 02	BU
MindMed Announces Voluntary Delisting from Cboe Canada	Apr. 01	BU
Mind Medicine Inc. announced that it has received $75 million in funding from Deep Track Capital, LP, Commodore Capital	Mar. 17	CI
MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference	Mar. 11	BU
RBC Raises Price Target on Mind Medicine (MindMed) to $22 From $15, Keeps Outperform, Speculative Risk	Mar. 08	MT
Numinus Wellness Congratulates Mindmed on Positive Results from Phase 2B Clinical Trials of Mm120 for Generalized Anxiety Disorder	Mar. 08	CI
Sector Update: Health Care Stocks Gain Late Afternoon	Mar. 07	MT
Sector Update: Health Care Stocks Stronger in Afternoon Trading	Mar. 07	MT
Roth MKM Raises Price Target on Mind Medicine to $36 From $25, Keeps Buy Rating	Mar. 07	MT
Mind Medicine Gets FDA Breakthrough for Anxiety Treatment, Sees $175 Million in Proceeds From Stock Offerings; Shares Jump	Mar. 07	MT
Mind Medicine MindMed : Investor Presentation - MM120 for Generalized Anxiety Disorder Conference Call and Webcast	Mar. 07	PU
Transcript : Mind Medicine Inc. - Special Call	Mar. 07
Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement	Mar. 07	BU
MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder	Mar. 07	BU
Mind Medicine Inc. Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data from Phase 2B Study of MM120 for Generalized Anxiety Disorder	Mar. 07	CI
Mind Medicine Inc. announced that it expects to receive $75 million in funding from Deep Track Capital, LP, Commodore Capital	Mar. 06	CI
Thinking about buying stock in Minim, GameSquare, Laser Photonics, Geron, or Mind Medicine?	Mar. 01	PR
MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120	Mar. 01	BU
RBC Lifts Price Target on Mind Medicine (MindMed) to $15 From $14, Notes Imminent Durability Data; Outperform, Speculative Risk Kept	Feb. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mind Medicine (MindMed) Inc. Other OTC

Equities

MMEDF

CA60255C1095

Summary

Filters